Alx Oncology Holdings, Inc. (ALXO) has disclosed a new risk, in the Share Price & Shareholder Rights category.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alx Oncology Holdings, Inc. faces a heightened listing risk, as its prior failure to meet Nasdaq’s $1.00 minimum bid requirement and subsequent cure in September 2025 underscore ongoing vulnerability to future non‑compliance. Any renewed breach of Nasdaq standards could trigger delisting, impairing trading liquidity, constraining access to capital, and exerting downward pressure on its share price.
The average ALXO stock price target is $4.67, implying 128.92% upside potential.
To learn more about Alx Oncology Holdings, Inc.’s risk factors, click here.